Trials / Completed
CompletedNCT01217216
Cancer Survival Through Weight Loss and Exercise
Cancer Survival Through Weight Loss and Exercise (CASTLE)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Pennington Biomedical Research Center · Academic / Other
- Sex
- Female
- Age
- 30 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To test the effectiveness and feasibility of intensive motivational, behavior modifying intervention aimed at improving physical activity and dietary habits to produce at least 7% weight loss in women with a history of breast cancer in a community health setting.
Detailed description
This study will be divided into two phases (Phase I and II) that will differ by the intensity of motivational intervention. In Phase I, participants will receive 6 months of intensive weekly group-based or telephone-based motivational, behavior modifying intervention aimed at improving physical activity levels and dietary habits. Phase II will be an additional 6 months of monthly individualized motivational intervention in order to attain and maintain at least 7% body weight loss. All participants will attend an orientation, 2 run-in sessions, and a baseline assessment prior to the intervention. Participants will then be assigned to either the group based intervention or telephone intervention. The first 30 participants will enter into the group-based intervention and the second 30 will enter into the telephone-based intervention. Follow-up visits will be completed at the end of Phase I (week 25) and Phase II (week 50). Up to 60 women with a previous history of breast cancer will participate in this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Group-based Intervention | compared effects of a group-based intervention on weight loss and physical activity. |
| BEHAVIORAL | Telephone-based Intervention | compared telephone-based intervention to weight loss and physical activity. |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2010-10-01
- Completion
- 2010-10-01
- First posted
- 2010-10-08
- Last updated
- 2022-09-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01217216. Inclusion in this directory is not an endorsement.